Speaker Profile
PhD, Head of JLABS San Francisco Region, Johnson & Johnson
Biography
Chris recently joined the Johnson and Johnson Innovation team to lead the JLabs activities in the San Francisco region. Prior to this he ran Bayers West Coast Open Innovation Center, located in the Mission Bay neighborhood of San Francisco, California. The Open Innovation Center supported Bayers Drug Discovery activities by developing and managing partnerships with U.S. academic research institutions and life science companies. Chris also actively participated in the local Bay Area startup ecosystem, contributing to various initiatives that aimed to support the growth and success of early biotech companies. He has served as a mentor in various startup support programs affiliated with organizations such as QB3, SkyDeck, and the California Life Science FAST program. Throughout his career, Chris has worked closely with emerging startups in the Bay Area, from strategy development to execution of strategic partnerships, across many domains including antibody discovery, genomics, and immune-oncology cell therapy.
Talk
Advancing New Healthcare Solutions Through Collaboration
Johnson Johnson Innovation believes a great idea can come from anywhere and that it takes partnership to turn ideas into breakthroughs. Learn how we connect potential collaborators and entrepreneurs to world-leading resources and aim to support them to advance transformational science and technology across the spectrum of innovative medicine and medtech
Non-Clinical Services Showcase:
Johnson and Johnson
Johnson & Johnson Innovation works across the Innovative Medicine and MedTech sectors to accelerate early-stage, transformational solutions by catalyzing the best ideas, wherever they are in the world.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Non-Clinical Services Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
